ArticleEnvironmental advances2025
Clinical correlation of SARS-CoV-2 wastewater passive sampling in long-term care facilities and wastewater treatment plants.
Article in Environmental advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Wastewater-based surveillance of ESKAPE pathogens in resource-limited countries (RLCs): an essential tool for monitoring antibiotic resistance.Environmental monitoring and assessment · 2026Review
- Long-term wastewater surveillance of SARS-CoV-2: a 5.5-year study reveals correlation with public health indicators and early warning potential during and after the pandemic.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Wastewater-based epidemiology (WBE) is a promising tool for improving health outcomes through early detection and cost-effective pathogen surveillance. Long-term care facilities (LTCFs) serve and employ vulnerable populations that may particularly benefit from the use of WBE, but financial and technical costs associated with standard sampling methods limit the feasibility of WBE in the LTCF setting. In this work, we used passive sampling to simplify the wastewater analysis process and compared its performance to the standard composite sampling method. Moore swabs and automatic composite samplers were used concurrently to sample wastewater from two LTCFs, and samples were analyzed for SARS-CoV-2 concentration. Passive sampling relies on an unknown volume of wastewater flowing through a cotton material, which complicates back calculations of pathogen concentration. We chose to calculate analyte concentrations based on the squeezed eluent from the cotton swab, which is practical for temporal analysis. Across all samples, passive and composite sampling performed similarly for SARS-CoV-2 detection and mean concentration. However, we observed a sensitivity advantage at low SARS-CoV-2 concentrations (<180 gc/mL) when using passive sampling. Furthermore, SARS-CoV-2 wastewater concentrations obtained via passive sampling correlated with the reported clinical cases, with wastewater concentration leading reported clinical cases by an average of 4 days. Passive and composite sampling were also performed at a wastewater treatment plant (WWTP) to examine the effects of facility type on sampling performance. To our knowledge, this is the first work performing a comparative analysis at both facility- and community-scale locations. Passive sampling yielded significantly higher SARS-CoV-2 and fecal load biomarkers than composite sampling at WWTPs, illustrating an important difference between LTCF samples and WWTP samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.